Abstract submissions for the annual MedStar Health—Georgetown University Research Symposium are now open! The Symposium offers the opportunity to connect with researchers, residents, and executive leaders to further advance the health of our community. All MedStar physicians, nurses, researchers, staff and residents/fellows are encouraged to submit abstracts. Submissions close at 11:59 pm on Thursday, February 28.
Program Director of the MedStar Diabetes Institute Joins ADA National Board of Directors
Gretchen Youssef, MS, RD, CDE, President, Health Care & Education became a member of the American Diabetes Association Principal Officers and National Board of Directors for 2019. The American Diabetes Association (ADA) is the nation's leading voluntary health organization on a mission to prevent and cure diabetes, as well as improve the lives of all people affected by the disease.
MedStar Health Awarded Grant to Improve Hepatitis C Diagnosis Clinical Knowledge at Point of Care
The Coverys Community Healthcare Foundation, Inc. (Foundation) put out a call to action and distributed a request for proposals for projects focused on improving diagnostic accuracy. The Foundation put aside $3 million in funding for approved projects. The Foundation received an overwhelming response to the request for proposals and MedStar Health’s proposal, titled “Improving diagnostic accuracy for Hepatitis C with a validated teach/improve model” was one of the 11 grant recipients selected for funding.
Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment
MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD.